Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Syndromes, Hereditary

Explore clinical trials studying Neoplastic Syndromes, Hereditary. Study availability and eligibility vary by location and protocol.

869 public trials 154 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Syndromes, Hereditary trial results

Completed

Colonoscopy Check-up in People With Lynch Syndrome

NCT06126120

Conditions
Colonic Diseases, Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, +15 more
Locations
  • Cancer Screening and Prevention Research Group (CSPRG), Department of Surgery and Cancer, Queen Elizabeth The Queen Mother (QEQM) Building, St Mary's Hospital, Imperial College London London, United Kingdom
View Trial Details
Completed

Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

NCT00945009

Conditions
Abnormalities, Multiple, Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome, +28 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 169 locations
View Trial Details
Completed

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

NCT00352534

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 240 locations
View Trial Details
Completed

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

NCT03433183

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +22 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study of Kidney Tumors in Younger Patients

NCT00898365

Conditions
Adenocarcinoma, Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, +46 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
View all 248 locations
View Trial Details
Completed

Gait in Rare Diseases

NCT05161494

Conditions
Central Nervous System Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations
  • University of Antwerp Antwerp, Belgium
View Trial Details
Completed

A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

NCT05864846

Conditions
Behavior, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Florida Health - Department of Neurology Gainesville, Florida, United States
  • Nicklaus Children's Health, Miami Miami, Florida, United States
View all 19 locations
View Trial Details
Completed

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

NCT03213678

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +82 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 127 locations
View Trial Details

Related conditions